Update shared on09 Oct 2025
Fair value Decreased 4.35%Arkema's analyst price target has been revised downward from €76.06 to €72.75. This change reflects analysts' expectations for slower revenue growth and a higher discount rate, even though profit margins have seen slight improvement.
Analyst Commentary
Recent analyst updates on Arkema present a mix of optimistic outlooks and cautious positioning, reflecting evolving views on the company's valuation, execution, and growth prospects as market dynamics change.
Bullish Takeaways
- Bullish analysts maintain Buy ratings and highlight long-term confidence in Arkema's strategic positioning and growth initiatives.
- Despite lowered targets, updates indicate only modest reductions in price expectations. This suggests analysts view Arkema's fundamental performance as relatively stable.
- Some target adjustments reflect improved profit margins. This supports the case for operational efficiency and future upside as market conditions normalize.
- Potential for higher earnings is still seen based on the company’s ongoing investment in high-growth specialty materials segments.
Bearish Takeaways
- Bearish analysts point to a more challenging macroeconomic environment, which results in lower price targets and neutral ratings.
- The pace of revenue growth has slowed and raises concerns about Arkema’s ability to accelerate top-line expansion in the near term.
- Higher discount rates and cautious sentiment toward cyclical sectors lead to further conservatism in valuation assumptions.
- There is heightened attention to potential risks in execution and end-market demand, which tempers overall enthusiasm even among prior bulls.
What's in the News
- Arkema's polyester powder coating resins site in North Kansas City, Missouri has received ISCC PLUS certification, making all company powder resins facilities globally certified for sustainable sourcing. (Key Developments)
- This achievement supports Arkema’s Mass Balance powder resins roadmap, which covers facilities in the US, Spain, and India and facilitates the supply of sustainable coatings solutions across multiple industries. (Key Developments)
- Arkema has successfully started up its 15 kt Forane 1233zd production unit in Calvert City, Kentucky. This expansion enables the development of low Global Warming Potential fluorospecialties and provides more sustainable solutions for building insulation and thermal management. (Key Developments)
- The new Forane FBA 1233zd blowing agent offers a non-ozone depleting solution with 99% lower GWP compared to previous HFCs, and is now available for the polyurethane foam and cooling markets. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has decreased from €76.06 to €72.75, reflecting a modest adjustment.
- Discount Rate has risen slightly from 8.53% to 8.68%, indicating a more cautious approach to future cash flows.
- Revenue Growth expectations have fallen significantly from 2.78% to 1.61%.
- Net Profit Margin has improved from 4.12% to 4.79%, showing enhanced profitability assumptions.
- Future P/E has declined from 18.0x to 15.3x, suggesting a lower valuation for projected earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.